Pentraxin 3 induces vascular endothelial dysfunction through a P-selectin/matrix metalloproteinase-1 pathway

Circulation

Volumn 131, Issue 17, 2015, Pages 1495-1505

  Carrizzo, Albino ^a   Lenzi, Paola ^b   Procaccini, Claudio ^c   Damato, Antonio ^a   Biagioni, Francesca ^a   Ambrosio, Mariateresa ^a   Amodio, Giuseppina ^d   Remondelli, Paolo ^d   Del Giudice, Carmine ^c   Izzo, Raffaele ^c   Malovini, Alberto ^e   Formisano, Luigi ^f   Gigantino, Vincenzo ^c,g   Madonna, Michele ^a   Puca, Annibale A ^d,h   Trimarco, Bruno ^c   Matarese, Giuseppe ^d,h   Fornai, Francesco ^a,b   Vecchione, Carmine ^a,d  

^a IRCCS NEUROMED   (Italy)

^b UNIVERSITY OF PISA   (Italy)

^c UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^d UNIVERSITY OF SALERNO   (Italy)

^e UNIVERSITY OF PAVIA   (Italy)

^f UNIVERSITY OF SANNIO   (Italy)

^g NATIONAL CANCER INSTITUTE   (Italy)

^h IRCCS MULTIMEDICA   (Italy)

Author keywords

Biological markers; Endothelium; Hypertension; Nitric oxide

Indexed keywords

AMYLOID PROTEIN; C REACTIVE PROTEIN; CAVEOLIN 1; ENDOTHELIAL NITRIC OXIDE SYNTHASE; FC RECEPTOR IIB; GELATINASE B; INTERSTITIAL COLLAGENASE; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE; PADGEM PROTEIN; PENTRAXIN 3; CAV1 PROTEIN, HUMAN; FC RECEPTOR; NERVE PROTEIN; NEURONAL PENTRAXIN; SERUM AMYLOID P;

ANIMAL EXPERIMENT; ANIMAL MODEL; AREA UNDER THE CURVE; ARTICLE; BIOTINYLATION; BLOOD PRESSURE REGULATION; BLOOD VESSEL REACTIVITY; BLOOD VESSEL TONE; CELL MEMBRANE; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOPLASM; ELEVATED BLOOD PRESSURE; ENDOTHELIAL DYSFUNCTION; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN CELL; HYPERTENSION; IN VITRO STUDY; IN VIVO STUDY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; RECEIVER OPERATING CHARACTERISTIC; RESISTANCE BLOOD VESSEL; SIGNAL TRANSDUCTION; SMOOTH MUSCLE CONTRACTION; UMBILICAL VEIN ENDOTHELIAL CELL; VASOCONSTRICTION; VASODILATATION; ANIMAL; BLOOD PRESSURE; C57BL MOUSE; CELL CULTURE; DEFICIENCY; KNOCKOUT MOUSE; METABOLISM; PATHOPHYSIOLOGY; PHYSIOLOGY; VASCULAR ENDOTHELIUM;

ANIMALS; BLOOD PRESSURE; C-REACTIVE PROTEIN; CAVEOLIN 1; CELL MEMBRANE; CELLS, CULTURED; ENDOTHELIUM, VASCULAR; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HUMANS; HYPERTENSION; MATRIX METALLOPROTEINASE 1; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; NERVE TISSUE PROTEINS; NITRIC OXIDE; P-SELECTIN; RECEPTORS, IGG; SERUM AMYLOID P-COMPONENT; SIGNAL TRANSDUCTION; VASODILATION;

EID: 84929377955     PISSN: 00097322     EISSN: 15244539     Source Type: Journal    
DOI: 10.1161/CIRCULATIONAHA.114.014822     Document Type: Article

References (42)

1. Moalli F, Jaillon S, Inforzato A, Sironi M, Bottazzi B, Mantovani A, Garlanda C. Pathogen recognition by the long pentraxin PTX3. J Biomed Biotechnol. 2011;2011:830421. doi: 10.1155/2011/830421.
2. Inforzato A, Bottazzi B, Garlanda C, Valentino S, Mantovani A. Pentraxins in humoral innate immunity. Adv Exp Med Biol. 2012;946:1-20. doi: 10.1007/978-1-4614-0106-3-1.
3. Mantovani A, Valentino S, Gentile S, Inforzato A, Bottazzi B, Garlanda C. The long pentraxin PTX3: a paradigm for humoral pattern recognition molecules. Ann N Y Acad Sci. 2013;1285:1-14. doi: 10.1111/nyas.12043.
4. Bottazzi B, Vouret-Craviari V, Bastone A, De Gioia L, Matteucci C, Peri G, Spreafico F, Pausa M, D'Ettorre C, Gianazza E, Tagliabue A, Salmona M, Tedesco F, Introna M, Mantovani A. Multimer formation and ligand recognition by the long pentraxin PTX3: similarities and differences with the short pentraxins C-reactive protein and serum amyloid P component. J Biol Chem. 1997;272:32817-32823.
5. Introna M, Alles VV, Castellano M, Picardi G, De Gioia L, Bottazzai B, Peri G, Breviario F, Salmona M, De Gregorio L, Dragani TA, Srinivasan N, Blundell TL, Hamilton TA, Mantovani A. Cloning of mouse ptx3, a new member of the pentraxin gene family expressed at extrahepatic sites. Blood. 1996;87:1862-1872.
6. Garlanda C, Bottazzi B, Bastone A, Mantovani A. Pentraxins at the crossroads between innate immunity, inflammation, matrix deposition, and female fertility. Annu Rev Immunol. 2005;23:337-366. doi: 10.1146/annurev.immunol.23.021704.115756.
7. Basile A, Sica A, d'Aniello E, Breviario F, Garrido G, Castellano M, Mantovani A, Introna M. Characterization of the promoter for the human long pentraxin PTX3: role of NF-kappaB in tumor necrosis factor-alpha and interleukin-1beta regulation. J Biol Chem. 1997;272:8172-8178.
8. Norata GD, Garlanda C, Catapano AL. The long pentraxin PTX3: a modulator of the immunoinflammatory response in atherosclerosis and cardiovascular diseases. Trends Cardiovasc Med. 2010;20:35-40. doi: 10.1016/j.tcm.2010.03.005.
9. Parlak A, Aydoʇan U, Iyisoy A, Dikililer MA, Kut A, Cakir E, Saʇlam K. Elevated pentraxin-3 levels are related to blood pressure levels in hypertensive patients: an observational study. Anadolu Kardiyol Derg. 2012;12:298-304. doi: 10.5152/akd.2012.092.
10. Presta M, Camozzi M, Salvatori G, Rusnati M. Role of the soluble pattern recognition receptor PTX3 in vascular biology. J Cell Mol Med. 2007;11:723-738. doi: 10.1111/j.1582-4934.2007.00061.x.
11. Booth AD, Jayne DR, Kharbanda RK, McEniery CM, Mackenzie IS, Brown J, Wilkinson IB. Infliximab improves endothelial dysfunction in systemic vasculitis: a model of vascular inflammation. Circulation. 2004;109:1718-1723. doi: 10.1161/01.CIR.0000124720.18538.DD.
12. Witasp A, Rydén M, Carrero JJ, Qureshi AR, Nordfors L, Näslund E, Hammarqvist F, Arefin S, Kublickiene K, Stenvinkel P. Elevated circulating levels and tissue expression of pentraxin 3 in uremia: a reflection of endothelial dysfunction. PLoS One. 2013;8:e63493. doi: 10.1371/journal.pone.0063493.
13. Hamad RR, Eriksson MJ, Berg E, Larsson A, Bremme K. Impaired endothelial function and elevated levels of pentraxin 3 in early-onset preeclampsia. Acta Obstet Gynecol Scand. 2012;91:50-56. doi: 10.1111/j.1600-0412.2011.01238.x.
14. Cozzi V, Garlanda C, Nebuloni M, Maina V, Martinelli A, Calabrese S, Cetin I. PTX3 as a potential endothelial dysfunction biomarker for severity of preeclampsia and IUGR. Placenta. 2012;33:1039-1044. doi: 10.1016/j.placenta.2012.09.009.
15. Suliman ME, Yilmaz MI, Carrero JJ, Qureshi AR, Saglam M, Ipcioglu OM, Yenicesu M, Tong M, Heimbürger O, Barany P, Alvestrand A, Lindholm B, Stenvinkel P. Novel links between the long pentraxin 3, endothelial dysfunction, and albuminuria in early and advanced chronic kidney disease. Clin J Am Soc Nephrol. 2008;3:976-985. doi: 10.2215/CJN.03960907.
16. Iiyama K, Nagano M, Yo Y, Nagano N, Kamide K, Higaki J, Mikami H, Ogihara T. Impaired endothelial function with essential hypertension assessed by ultrasonography. Am Heart J. 1996;132:779-782.
17. Moalli F, Doni A, Deban L, Zelante T, Zagarella S, Bottazzi B, Romani L, Mantovani A, Garlanda C. Role of complement and Fc{gamma} receptors in the protective activity of the long pentraxin PTX3 against Aspergillus fumigatus. Blood. 2010;116:5170-5180. doi: 10.1182/blood-2009-12-258376.
18. Deban L, Russo RC, Sironi M, Moalli F, Scanziani M, Zambelli V, Cuccovillo I, Bastone A, Gobbi M, Valentino S, Doni A, Garlanda C, Danese S, Salvatori G, Sassano M, Evangelista V, Rossi B, Zenaro E, Constantin G, Laudanna C, Bottazzi B, Mantovani A. Regulation of leukocyte recruitment by the long pentraxin PTX3. Nat Immunol. 2010;11:328-334. doi: 10.1038/ni.1854.
19. Ji Z, Ke ZJ, Geng JG. SAP suppresses the development of experimental autoimmune encephalomyelitis in C57BL/6 mice. Immunol Cell Biol. 2012;90:388-395. doi: 10.1038/icb.2011.51.
20. Sundgren NC, Zhu W, Yuhanna IS, Chambliss KL, Ahmed M, Tanigaki K, Umetani M, Mineo C, Shaul PW. Coupling of Fcgamma receptor I to Fcgamma receptor IIb by SRC kinase mediates C-reactive protein impairment of endothelial function. Circ Res. 2011;109:1132-1140.
21. Ignarro LJ. Nitric oxide as a unique signaling molecule in the vascular system: a historical overview. J Physiol Pharmacol. 2002;53(pt 1):503-514.
22. Volpe M, Iaccarino G, Vecchione C, Rizzoni D, Russo R, Rubattu S, Condorelli G, Ganten U, Ganten D, Trimarco B, Lindpaintner K. Association and cosegregation of stroke with impaired endothelium-dependent vasorelaxation in stroke prone, spontaneously hypertensive rats. J Clin Invest. 1996;98:256-261. doi: 10.1172/JCI118787.
23. Zaloudíková M, Herget J, Vízek M. The contractile response of isolated small pulmonary arteries induced by activated macrophages. Physiol Res. 2014;63:267-270.
24. Rajamannan NM, Springett MJ, Pederson LG, Carmichael SW. Localization of caveolin 1 in aortic valve endothelial cells using antigen retrieval. J Histochem Cytochem. 2002;50:617-628.
25. Zerr M, Hechler B, Freund M, Magnenat S, Lanois I, Cazenave JP, Leon C, Gachet C. Major contribution of the P2Y(1)receptor in purinergic regulation of TNFalpha-induced vascular inflammation. Circulation. 2011;123:2404-2413.
26. Ushiyama S, Laue TM, Moore KL, Erickson HP, McEver RP. Structural and functional characterization of monomeric soluble P-selectin and comparison with membrane P-selectin. J Biol Chem. 1993;268:15229-15237.
27. Harrington JM, Chou HT, Gutsmann T, Gelhaus C, Stahlberg H, Leippe M, Armstrong PB. Membrane pore formation by pentraxin proteins from Limulus, the American horseshoe crab. Biochem J. 2008;413:305-313. doi: 10.1042/BJ20071357.
28. Förstermann U, Münzel T. Endothelial nitric oxide synthase in vascular disease: from marvel to menace. Circulation. 2006;113:1708-1714. doi: 10.1161/CIRCULATIONAHA.105.602532.
29. Puca AA, Carrizzo A, Ferrario A, Villa F, Vecchione C. Endothelial nitric oxide synthase, vascular integrity and human exceptional longevity. Immun Ageing. 2012;9:26. doi: 10.1186/1742-4933-9-26.
30. Feron O, Belhassen L, Kobzik L, Smith TW, Kelly RA, Michel T. Endothelial nitric oxide synthase targeting to caveolae: specific interactions with caveolin isoforms in cardiac myocytes and endothelial cells. J Biol Chem. 1996;271:22810-22814.
31. Minshall RD, Sessa WC, Stan RV, Anderson RG, Malik AB. Caveolin regulation of endothelial function. Am J Physiol Lung Cell Mol Physiol. 2003;285:L1179-L1183. doi: 10.1152/ajplung.00242.2003.
32. Komers R, Schutzer WE, Reed JF, Lindsley JN, Oyama TT, Buck DC, Mader SL, Anderson S. Altered endothelial nitric oxide synthase targeting and conformation and caveolin-1 expression in the diabetic kidney. Diabetes. 2006;55:1651-1659. doi: 10.2337/db05-1595.
33. Souza DG, Amaral FA, Fagundes CT, Coelho FM, Arantes RM, Sousa LP, Matzuk MM, Garlanda C, Mantovani A, Dias AA, Teixeira MM. The long pentraxin PTX3 is crucial for tissue inflammation after intestinal ischemia and reperfusion in mice. Am J Pathol. 2009;174:1309-1318. doi: 10.2353/ajpath.2009.080240.
34. Zhu H, Cui D, Liu K, Wang L, Huang L, Li J. Long pentraxin PTX3 attenuates ischemia reperfusion injury in a cardiac transplantation model. Transpl Int. 2014;27:87-95. doi: 10.1111/tri.12197.
35. Souza DG, Soares AC, Pinho V, Torloni H, Reis LF, Teixeira MM, Dias AA, Martins MT. Increased mortality and inflammation in tumor necrosis factor-stimulated gene-14 transgenic mice after ischemia and reperfusion injury. Am J Pathol. 2002;160:1755-1765.
36. Pardo A, Selman M. MMP-1: the elder of the family. Int J Biochem Cell Biol. 2005;37:283-288. doi: 10.1016/j.biocel.2004.06.017.
37. Galis ZS, Khatri JJ. Matrix metalloproteinases in vascular remodeling and atherogenesis: the good, the bad, and the ugly. Circ Res. 2002;90:251-262.
38. Lee SW, Song KE, Shin DS, Ahn SM, Ha ES, Kim DJ, Nam MS, Lee KW. Alterations in peripheral blood levels of TIMP-1, MMP-2, and MMP-9 in patients with type-2 diabetes. Diabetes Res Clin Pract. 2005;69:175-179. doi: 10.1016/j.diabres.2004.12.010.
39. Death AK, Fisher EJ, McGrath KC, Yue DK. High glucose alters matrix metalloproteinase expression in two key vascular cells: potential impact on atherosclerosis in diabetes. Atherosclerosis. 2003;168:263-269.
40. Morillas P, Quiles J, de Andrade H, Castillo J, Tarazón E, Roselló E, Portolés M, Rivera M, Bertomeu-Martínez V. Circulating biomarkers of collagen metabolism in arterial hypertension: relevance of target organ damage. J Hypertens. 2013;31:1611-1617. doi: 10.1097/HJH.0b013e3283614c1c.
41. Blann AD, Nadar SK, Lip GY. The adhesion molecule P-selectin and cardiovascular disease. Eur Heart J. 2003;24:2166-2179.
42. Ridker PM, Buring JE, Rifai N. Soluble P-selectin and the risk of future cardiovascular events. Circulation. 2001;103:491-495.